Cargando…

Neoadjuvant radiotherapy in triple-negative breast cancer: “the past should not steal the present or hide the future”

Detalles Bibliográficos
Autores principales:	To, Nhu Hanh, Radosevic-Robin, Nina, Belkacemi, Yazid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Via Medica 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989450/ https://www.ncbi.nlm.nih.gov/pubmed/35402032 http://dx.doi.org/10.5603/RPOR.a2022.0127

Ejemplares similares

Atypical responses to neoadjuvant chemotherapy combined with accelerated partial breast tumor-directed radiotherapy: two cases and considerations for future clinical trials
por: To, Nhu Hanh, et al.
Publicado: (2022)

Pathologic Response to Neoadjuvant Sequential Chemoradiation Therapy in Locally Advanced Breast Cancer: Preliminary, Translational Results from the French Neo-APBI-01 Trial
por: To, Nhu Hanh, et al.
Publicado: (2023)

Adaptive Radiotherapy for an Uncommon Chloroma
por: Majdoul, Soufya, et al.
Publicado: (2016)

Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients
por: Lusho, Sejdi, et al.
Publicado: (2021)

Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies
por: Radosevic-Robin, Nina, et al.
Publicado: (2021)

[(18)F]ML-10 PET imaging fails to assess early response to neoadjuvant chemotherapy in a preclinical model of triple negative breast cancer
por: Jouberton, Elodie, et al.
Publicado: (2020)

Who steals my identity steals trash
por: Petsko, Gregory A
Publicado: (2005)

Stealing histones
por: LeBrasseur, Nicole
Publicado: (2006)

They Steal for Love
por: Addis, R. S.
Publicado: (1959)

Higher locoregional recurrence rate for triple-negative breast cancer following neoadjuvant chemotherapy, surgery and radiotherapy
por: Zhang, Chi, et al.
Publicado: (2015)

Neoadjuvant Chemotherapy for Breast Cancer: Past, Present, and Future
por: Asaoka, Mariko, et al.
Publicado: (2020)

Image guidance: past and future of radiotherapy
por: Herrmann, H., et al.
Publicado: (2019)

The Anti-allergic Cromones: Past, Present, and Future
por: Sinniah, Ajantha, et al.
Publicado: (2017)

Hide yourself, hide yourself, hide yourself!
Publicado: (2020)

Transient memory steal: A rare phenomenon of subclavian steal syndrome
por: Shanmugasundaram, R, et al.
Publicado: (2015)

Radiation Therapy Delivery Challenges in Older Patients During Coronavirus Disease 2019 Pandemic
por: Cherif, Mohamed Aziz, et al.
Publicado: (2020)

Combining radiotherapy with immunotherapy: the past, the present and the future
por: Van Limbergen, Evert J, et al.
Publicado: (2017)

Stealing the Corner Office
por: Reid, Brendan
Publicado: (2014)

On the art of stealing chloroplasts
por: Cartaxana, Paulo, et al.
Publicado: (2020)

Thou Shalt Not Steal
Publicado: (1887)

Alexa is stealing your job: the impact of artificial intelligence on your future
por: Scharf, Rhonda
Publicado: (2019)

Advances and Challenges in Breast Cancer Management: A History Made of Evolutions and Revolutions
por: Belkacemi, Yazid
Publicado: (2023)

INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse of Triple Negative Breast Cancer
por: Veyssière, Hugo, et al.
Publicado: (2021)

Triple-Negative Breast Cancer: An Update on Neoadjuvant Clinical Trials
por: Amos, Keith D., et al.
Publicado: (2012)

Controversial issues in the neoadjuvant treatment of triple-negative breast cancer
por: Fitzpatrick, Amanda, et al.
Publicado: (2019)

Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: An Observational Study
por: Shao, Zhiying, et al.
Publicado: (2016)

Neoadjuvant immunotherapy in early-stage triple negative breast cancer
por: Laouris, Panayiotis, et al.
Publicado: (2023)

Current and Future Role of Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: Which Way to Go Forward
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy and Targeted Therapy in Breast Cancer: Past, Present, and Future
por: Gampenrieder, Simon P., et al.
Publicado: (2013)

Bilateral Subclavian Steal Syndrome
por: Amini, Reza, et al.
Publicado: (2011)

Unexpected Stealing From the Heart
por: Jones-Ince, Ingrid, et al.
Publicado: (2016)

“Asymptomatic” Subclavian Steal Syndrome
por: Amano, Yu, et al.
Publicado: (2021)

XENOBREAST Trial: A prospective study of xenografts establishment from surgical specimens of patients with triple negative or luminal b breast cancer
por: Veyssière, Hugo, et al.
Publicado: (2021)

Mismatch negativity–stimulation paradigms in past and in future
por: Tervaniemi, Mari
Publicado: (2022)

The Role of Carboplatin in the Neoadjuvant Chemotherapy Treatment of Triple Negative Breast Cancer
por: Castrellon, Aurelio Bartolome, et al.
Publicado: (2017)

Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges
por: Lee, Jin Sun, et al.
Publicado: (2020)

Immune responses during neoadjuvant chemotherapy in triple negative breast cancer
por: Ghallab, Ahmed
Publicado: (2020)

Therapeutic pattern and progress of neoadjuvant treatment for triple-negative breast cancer
por: Xiao, Yan, et al.
Publicado: (2022)

Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
por: Ding, Feng, et al.
Publicado: (2022)

Evolving Evidence for the Optimization of Neoadjuvant Therapy in Triple-Negative Breast Cancer
por: Silva, Diogo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t1p4dfid1sq2ump988t0c0jtn5